Cargando…

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

Vulvovaginal atrophy (VVA) and dryness are common symptoms of the decline in endogenous production of estrogen at menopause and often result in dyspareunia. Yet while 10% to 40% of women experience discomfort due to VVA, it is estimated that only 25% seek medical help. The main goals of treatment fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kingsberg, SA, Kellogg, S, Krychman, M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971714/
https://www.ncbi.nlm.nih.gov/pubmed/21072280